John Lewis Etter

John Lewis Etter.

John Lewis Etter

John Lewis Etter

Thesis Title

Characterizing novel reproductive and molecular markers of ovarian cancer risk

Research Publications Overview

Publications

  • Etter JL, Moysich K, Kohli S, Lele S, Odunsi K, Eng KH. Transmission of X-linked Ovarian Cancer: Characterization and Implications. Diagnostics. 2020; 10(2):90. 
  • Fried J, Etter JL, Stenzel AE, Joseph JM, Cannioto R, Danziger IR, Moysich KB. Physical inactivity and head and neck cancer mortality. Head & Neck. 2020; 1-8.
  • Etter JL, Cannioto R, Soh KT, Alquassim E, Almohanna H, Dunbar Z, et al. Lifetime physical inactivity is associated with increased risk for Hodgkin and non-Hodgkin lymphoma: A case-control study. Leukemia research. 2018;69:7-11.
  • Etter JL, Eng K, Cannioto R, Kaur J, Almohanna H, Alqassim E, et al. Hereditary association between testicular cancer and familial ovarian cancer: A Familial Ovarian Cancer Registry study. Cancer epidemiology. 2018;53:184-6.
  • Cannioto R, Etter JL, LaMonte MJ, Ray AD, Joseph JM, Al Qassim E, et al. Lifetime physical inactivity is associated with lung cancer risk and mortality. Cancer treatment and research communications. 2018;14:37-45.
  • Eng KH, Szender JB, Etter JL, Kaur J, Poblete S, Huang RY, et al. Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS genetics. 2018;14(2):e1007194.
  • Minlikeeva AN, Moysich KB, Mayor PC, Etter JL, Cannioto RA, Ness RB, Starbuck K, Edwards RP, Segal BH, Lele S, Odunsi K, Diergaarde B, Modugno F. Anthropometric characteristics and ovarian cancer risk and survival. Cancer Causes Control. 2018 Jan 11. doi: 10.1007/s10552-017-0997-5. [Epub ahead of print] PubMed PMID: 29327114. 
  • Minlikeeva AN, Freudenheim JL, Cannioto RA, Eng KH, Szender JB, Mayor P, Etter JL, Cramer DW, Diergaarde B, Doherty JA, Dörk T, Edwards R, deFazio A, Friel G, Goodman MT, Hillemanns P, Høgdall E, Jensen A, Jordan SJ, Karlan BY, Kjær SK, Klapdor R, Matsuo K, Mizuno M, Nagle CM, Odunsi K, Paddock L, Rossing MA, Schildkraut JM, Schmalfeldt B, Segal BH, Starbuck K, Terry KL, Webb PM, Zsiros E, Ness RB, Modugno F, Bandera EV, Chang-Claude J, Moysich KB. History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report. Br J Cancer. 2017 Aug 17. doi:10.1038/bjc.2017.267. Epub 2017 Aug 17. PubMed PMID: 28817835; PubMed Central PMCID: PMC5625672. 
  • Platek A*, Cannioto R*, Etter JL, Kim J, Joseph JM, Gulati NR, Schmitt KL, Callahan E, Khachatryan E, Nagy R, Minlikeeva A, Szender JB, Singh AK, Danziger I, Moysich KB. The association of lifetime physical inactivity with head and neck cancer: a hospital based case-control analysis. Eur Arch Otorhinolaryngol. 2017 Aug 5. doi: 10.1007/s00405-017-4688-3. Epub 2017 Aug 5. PubMed PMID: 28780667; PubMed Central PMCID: PMC5685923. 
  • Cannioto R, Etter JL, Guterman LB, Joseph JM, Gulati NR, Schmitt KL, et al. The association of lifetime physical inactivity with bladder and renal cancer risk: A hospital-based case-control analysis. Cancer epidemiology. 2017;49:24-9.
  • Sucheston-Campbell LE*, Cannioto R*, Clay AI, Etter JL, Eng KH, Liu S, Battaglia S, Hu Q, Szender JB, Minlikeeva A, Joseph J, Mayor P, Abrams SI, Segal B, WallacePK, Soh KT, Zsiros EZ, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bjørge L, Bruegl A, Campbell IG, Campbell SP, Chenevix-Trench G, Cramer D, Dansonka-Mieszkowska A, Dao F, Diergaarde B, Doerk T, Doherty JA, du Bois A, Eccles D, Engelholm SA, Fasching PA, Gayther SA, Gentry-Maharaj A, Glasspool RM, Goodman MT, Gronwald J, Harter P, Hein A, Heitz F, Hillemmanns P, Hogdall C, Høgdall EV, Huzarski T, Jensen A, Johnatty SE, Jung A, Karlan B, Klapdor R, Kluz T, Konopka B, Krüger Kjær S, Kupryjanczyk J, Lambrechts D, Lester J, Lubiński J, Levine DA, Lundvall L, McGuire V, McNeish IA, Menon U, Modugno F, Ness RB, Orsulic S, Paul J, Pearce CL, Pejovic T, Pharoah P, Ramus SJ, Rothstein J, Rossing MA, Rübner M, Schildkraut JM, Schmalfeldt B, Schwaab I, Siddiqui N, Sieh W, Sobiczewski P, Song H, Terry KL, Van Nieuwenhuysen E, Vanderstichele A, Vergote I, Walsh CS, Webb PM, Wentzensen N, Whittemore AS, Wu AH, Ziogas A, Odunsi K, Chang Claude J, Goode EL, Moysich KB. No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):420-424. doi: 10.1158/1055-9965.EPI-16-0631. PubMed PMID: 27677730.

Professional/Educational Meetings/Abstracts

  • Starbuck K, Cannioto RA, Etter JL, Moysich KB, Duncan W, Morrell K, Almohanna H, Joseph JM, Szender JB, Zsiros E, Odunsi K, Frederick PJ, Lele SB, Akers SN, Eng KH. “Variability in body mass index during adjuvant chemotherapy is associated with clinical outcomes among invasive ovarian cancer patients.” SGO Annual Meeting on Women’s Cancer, 18 September 2017.
  • Mayor PC, Fan K, Etter JL, Szender JB, Morrell K, Eng KH, Akers SN, Frederick PJ, Odunsi K, Lele SB, Zsiros E. “Operative time influences outcomes in patient’s undergoing pelvic exenteration for gynecologic malignancy: A NSQIP database analysis.” SGO Annual Meeting on Women’s Cancer, 18 September 2017. 
  • Mayor PC, Fan K, Etter JL, Morrell K, Eng KH, Szender JB, Akers SN, Frederick PJ, Lele SB, Odunsi K, Zsiros E. “Performing combined breast and gynecologic surgery does not increase the rate of post-operative morbidity: A NSQIP database analysis.” SGO Annual Meeting on Women’s Cancer, 18 September 2017. 
  • Starbuck K, Eng KH, Morrell K, Duncan W, Etter JL, Moysich KB, Odunsi K, Zsiros E, Frederick PJ, Akers SN, Lele SB, Szender JB. “Prognostic impact of adjuvant chemotherapy treatment delays for ovarian cancer – a cohort study.” SGO Annual Meeting on Women’s Cancer, 18 September 2017.